A Look At The Legality Behind Daraprim's Price Spike
Turing Pharmaceuticals AG and its controversial CEO Martin Shkreli recently made headlines when Turing raised the price of its antiprotozal drug Daraprim (pyrimethamine) from $13.50 to $750 per tablet.[1] The price...To view the full article, register now.
Already a subscriber? Click here to view full article